Jonathan A Bernstein Selected Research

Chronic Obstructive Pulmonary Disease (COPD)

1/2023	Can clinical characteristics differentiate patients with unexplained chronic cough from patients with asthma and COPD?
1/2019	Chronic Rhinitis Is a High-Risk Comorbidity for 30-Day Hospital Readmission of Patients with Asthma and Chronic Obstructive Pulmonary Disease.
1/2014	The 24-h FEV1 time profile of olodaterol once daily via Respimat® and formoterol twice daily via Aerolizer® in patients with GOLD 2-4 COPD: results from two 6-week crossover studies.
6/2012	Poor asthma control and exposure to traffic pollutants and obesity in older adults.
3/2011	MK-0633, a potent 5-lipoxygenase inhibitor, in chronic obstructive pulmonary disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jonathan A Bernstein Research Topics

Disease

58	Hereditary Angioedemas 01/2024 - 01/2008
44	Angioedema 05/2024 - 01/2008
42	Asthma (Bronchial Asthma) 11/2023 - 08/2002
32	Urticaria (Hives) 12/2024 - 01/2004
32	Chronic Urticaria 12/2024 - 08/2002
29	Hypersensitivity (Allergy) 01/2023 - 01/2003
23	Rhinitis 03/2024 - 03/2002
19	Anaphylaxis (Anaphylactic Shock) 12/2023 - 04/2011
11	Allergic Rhinitis 03/2024 - 03/2002
9	Neurodevelopmental Disorders 05/2024 - 01/2016
8	Vasomotor Rhinitis 03/2024 - 10/2007
8	Rhinosinusitis 01/2023 - 02/2007
6	Inflammation (Inflammations) 05/2024 - 11/2015
6	COVID-19 11/2023 - 05/2020
6	Intellectual Disability (Idiocy) 01/2022 - 10/2016
6	Inborn Genetic Diseases (Disease, Hereditary) 02/2021 - 01/2013
5	Chronic Obstructive Pulmonary Disease (COPD) 01/2023 - 03/2011
5	Acquired angioedema 12/2022 - 08/2002
5	Neoplasms (Cancer) 01/2022 - 08/2002
4	Pruritus (Itching) 05/2024 - 01/2022
4	Rare Diseases (Rare Disease) 01/2024 - 01/2014
4	Nasal Polyps (Nasal Polyp) 01/2023 - 01/2022
4	Timothy syndrome 01/2023 - 03/2011
4	Autoimmune progesterone dermatitis 01/2020 - 04/2011
4	Seizures (Absence Seizure) 01/2020 - 10/2014
4	Edema (Dropsy) 04/2015 - 08/2010
3	Chronic Cough 01/2023 - 12/2021
3	Cough 05/2022 - 01/2017
3	Microcephaly 10/2017 - 10/2014
3	Respiratory Hypersensitivity 05/2014 - 04/2005
2	Pain (Aches) 03/2024 - 03/2024
2	Atopic Dermatitis (Atopic Eczema) 03/2024 - 01/2018
2	Respiratory Tract Diseases (Respiratory Tract Disease) 02/2024 - 03/2013

Drug/Important Bio-Agent (IBA)

26	Omalizumab (Xolair)FDA Link 12/2024 - 09/2015
23	Complement C1 Inhibitor Protein (C1 Esterase Inhibitor)IBA 12/2022 - 10/2009
21	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2024 - 02/2007
20	Histamine Antagonists (Antihistamines)IBA 12/2024 - 03/2002
19	Proteins (Proteins, Gene)FDA Link 05/2024 - 01/2003
17	Immunoglobulin E (IgE)IBA 03/2024 - 06/2003
15	Biomarkers (Surrogate Marker)IBA 01/2023 - 11/2013
15	BradykininIBA 10/2022 - 01/2008
12	AllergensIBA 03/2024 - 11/2015
11	Plasma KallikreinIBA 12/2023 - 01/2010
9	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 12/2023 - 05/2013
8	azelastine (Optivar)FDA LinkGeneric 03/2024 - 10/2007
7	Irritants (Vesicants)IBA 02/2022 - 06/2009
7	ecallantide FDA Link 04/2016 - 01/2010
6	benralizumabIBA 02/2024 - 01/2020
6	Environmental Pollutants (Pollutants, Environmental)IBA 02/2024 - 03/2009
6	Monoclonal AntibodiesIBA 01/2023 - 09/2016
6	Tiotropium Bromide (Spiriva)FDA Link 09/2019 - 01/2017
6	icatibantIBA 11/2017 - 01/2008
5	dupilumabIBA 02/2024 - 01/2019
5	Histamine (Histamine Dihydrochloride)FDA Link 12/2023 - 11/2012
5	PrekallikreinIBA 11/2023 - 09/2019
5	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 11/2023 - 02/2007
5	Epinephrine (Adrenaline)FDA LinkGeneric 02/2023 - 11/2012
5	Progestins (Progestagens)IBA 01/2023 - 05/2017
5	lanadelumabIBA 01/2022 - 01/2017
5	Progesterone FDA LinkGeneric 01/2020 - 04/2011
5	Methacholine Chloride (Methacholine)FDA Link 10/2016 - 11/2009
4	RNA (Ribonucleic Acid)IBA 05/2024 - 01/2019
4	Fluticasone (Cutivate)FDA LinkGeneric 03/2024 - 10/2007
4	CytokinesIBA 12/2023 - 10/2010
4	ligelizumabIBA 11/2023 - 10/2019
4	Bronchodilator Agents (Bronchodilators)IBA 01/2023 - 11/2009
4	Complement System Proteins (Complement)IBA 01/2023 - 10/2010
4	GlucocorticoidsIBA 01/2022 - 01/2014
4	AntibodiesIBA 01/2022 - 11/2011
4	ChromatinIBA 01/2021 - 10/2014
4	Nasal SpraysIBA 08/2011 - 01/2005
3	Cetirizine (Zyrtec)FDA LinkGeneric 03/2024 - 01/2004
3	fexofenadine (Allegra)FDA LinkGeneric 03/2024 - 05/2022
3	berotralstatIBA 12/2023 - 01/2021
3	Tryptases (Tryptase)IBA 12/2023 - 01/2023
3	L-Type Calcium Channels (Dihydropyridine Receptor)IBA 01/2023 - 03/2011
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 05/2022 - 11/2009
3	Transcription Factors (Transcription Factor)IBA 01/2020 - 12/2017
3	Prednisone (Sone)FDA LinkGeneric 01/2020 - 08/2002
3	Arginine (L-Arginine)FDA Link 01/2018 - 10/2016
3	Capsaicin (Zostrix)FDA Link 05/2014 - 08/2011
3	Seminal Plasma ProteinsIBA 09/2011 - 01/2003
2	Phosphotransferases (Kinase)IBA 04/2024 - 11/2015
2	Therapeutic UsesIBA 02/2024 - 05/2014
2	AndrogensIBA 01/2024 - 01/2021
2	donidalorsenIBA 11/2023 - 01/2022
2	agalsidase beta FDA Link 11/2023 - 01/2021
2	mepolizumabIBA 11/2023 - 01/2020
2	AutoantibodiesIBA 11/2023 - 08/2002
2	VaccinesIBA 11/2023 - 06/2022
2	sebetralstatIBA 11/2023 - 09/2023

Therapy/Procedure

62	Therapeutics 12/2024 - 01/2004
5	Biological Therapy 11/2023 - 01/2019
5	Drug Therapy (Chemotherapy) 05/2022 - 08/2002
4	Immunotherapy 01/2022 - 01/2011
3	Injections 11/2023 - 08/2010
3	Premedication 01/2022 - 01/2020
3	Precision Medicine 10/2020 - 01/2018
3	Aftercare (After-Treatment) 04/2016 - 10/2009
2	Anesthesia 12/2023 - 05/2015